137 related articles for article (PubMed ID: 33450085)
1. MYC status in HIV-associated plasmablastic lymphoma: dual-colour CISH, FISH and immunohistochemistry.
Pather S; Mashele T; Willem P; Patel M; Perner Y; Motaung M; Nagiah N; Waja F; Philip V; Lakha A; Hale MJ
Histopathology; 2021 Jul; 79(1):86-95. PubMed ID: 33450085
[TBL] [Abstract][Full Text] [Related]
2. HIV-associated DLBCL: Clinicopathological factors including dual-colour chromogenic in situ hybridisation to assess MYC gene copies.
Pather S; Patel M
Ann Diagn Pathol; 2022 Jun; 58():151913. PubMed ID: 35299080
[TBL] [Abstract][Full Text] [Related]
3. High incidence of MYC rearrangement in human immunodeficiency virus-positive plasmablastic lymphoma.
Miao L; Guo N; Feng Y; Rao H; Wang F; Huang Q; Huang Y
Histopathology; 2020 Jan; 76(2):201-211. PubMed ID: 31348551
[TBL] [Abstract][Full Text] [Related]
4. Plasmablastic lymphomas show restricted EBV latency profile and
Ramburan A; Kriel R; Govender D
Leuk Lymphoma; 2022 Feb; 63(2):370-376. PubMed ID: 34612761
[TBL] [Abstract][Full Text] [Related]
5. Extraoral plasmablastic lymphomas in a high human immunodeficiency virus endemic area.
Meer S; Perner Y; McAlpine ED; Willem P
Histopathology; 2020 Jan; 76(2):212-221. PubMed ID: 31361906
[TBL] [Abstract][Full Text] [Related]
6. Oral versus extra-oral plasmablastic lymphoma: A comparative analysis of 101 cases.
Meer S; Perner Y; Willem P
J Oral Pathol Med; 2022 Feb; 51(2):146-151. PubMed ID: 34910327
[TBL] [Abstract][Full Text] [Related]
7. Transformation of double-hit follicular lymphoma to plasmablastic lymphoma: a partial role of MYC gene rearrangement.
Ise M; Kageyama H; Ikebe D; Araki A; Kumagai K; Itami M
J Clin Exp Hematop; 2018 Sep; 58(3):128-135. PubMed ID: 30012920
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia.
Elyamany G; Alzahrani AM; Aljuboury M; Mogadem N; Rehan N; Alsuhaibani O; Alabdulaaly A; Al-Mussaed E; Elhag I; AlFiaar A
Diagn Pathol; 2015 Jun; 10():78. PubMed ID: 26108914
[TBL] [Abstract][Full Text] [Related]
9. Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features.
Taddesse-Heath L; Meloni-Ehrig A; Scheerle J; Kelly JC; Jaffe ES
Mod Pathol; 2010 Jul; 23(7):991-9. PubMed ID: 20348882
[TBL] [Abstract][Full Text] [Related]
10. Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients.
Loghavi S; Alayed K; Aladily TN; Zuo Z; Ng SB; Tang G; Hu S; Yin CC; Miranda RN; Medeiros LJ; Khoury JD
J Hematol Oncol; 2015 Jun; 8():65. PubMed ID: 26055271
[TBL] [Abstract][Full Text] [Related]
11. IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas.
Valera A; Balagué O; Colomo L; Martínez A; Delabie J; Taddesse-Heath L; Jaffe ES; Campo E
Am J Surg Pathol; 2010 Nov; 34(11):1686-94. PubMed ID: 20962620
[TBL] [Abstract][Full Text] [Related]
12. Plasmablastic lymphoma: current knowledge and future directions.
Li JW; Peng HL; Zhou XY; Wang JJ
Front Immunol; 2024; 15():1354604. PubMed ID: 38415257
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and genetic landscape of plasmablastic lymphoma in Taiwan.
Chen BJ; Hsieh TH; Yuan CT; Wang RC; Yang CF; Chuang WY; Su YZ; Ho CH; Lin CH; Chuang SS
Pathol Res Pract; 2024 Jan; 253():155059. PubMed ID: 38160484
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of
Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
[No Abstract] [Full Text] [Related]
15. [Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens].
Yin WJ; Zhu X; Yang HY; Sun WY; Wu MJ
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):32-38. PubMed ID: 29325248
[No Abstract] [Full Text] [Related]
16. Plasmablastic myeloma in Taiwan frequently presents with extramedullary and extranodal mass mimicking plasmablastic lymphoma.
Chen BJ; Yuan CT; Yang CF; Ho CH; Lin YK; Su YZ; Chou HC; Chuang SS
Virchows Arch; 2022 Aug; 481(2):283-293. PubMed ID: 35657404
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases.
Morscio J; Dierickx D; Nijs J; Verhoef G; Bittoun E; Vanoeteren X; Wlodarska I; Sagaert X; Tousseyn T
Am J Surg Pathol; 2014 Jul; 38(7):875-86. PubMed ID: 24832164
[TBL] [Abstract][Full Text] [Related]
18. Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma.
Garcia-Reyero J; Martinez Magunacelaya N; Gonzalez de Villambrosia S; Loghavi S; Gomez Mediavilla A; Tonda R; Beltran S; Gut M; Pereña Gonzalez A; d'Ámore E; Visco C; Khoury JD; Montes-Moreno S
Haematologica; 2021 Apr; 106(4):1120-1128. PubMed ID: 32273478
[TBL] [Abstract][Full Text] [Related]
19. Plasmablastic lymphoma: from genetics to treatment.
Frontzek F; Hailfinger S; Lenz G
Leuk Lymphoma; 2023 Apr; 64(4):799-807. PubMed ID: 36577021
[TBL] [Abstract][Full Text] [Related]
20. Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas.
Leeman-Neill RJ; Soderquist CR; Montanari F; Raciti P; Park D; Radeski D; Mansukhani MM; Murty VV; Hsiao S; Alobeid B; Bhagat G
Haematologica; 2022 Jan; 107(1):201-210. PubMed ID: 33297669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]